copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
ChemLex AI-for-Science Startup ChemLex Raises USD 45M, Launching Self-Driving Lab for Drug Discovery in Singapore Singapore, 8 December 2025 — ChemLex, a next-generation AI-for-science company, recently announced the establishment of its global headquarters in Singapore, alongside the close of a USD 45 million funding led by Granite Asia
Chemistry AI startup ChemLex raises US$45 million, sets up . . . [SINGAPORE] ChemLex has raised a US$45 million funding round led by Granite Asia and established its global headquarters in Singapore The startup develops technologies to accelerate chemical discovery for the pharmaceutical industry ChemLex’s platform is a 24 7 autonomous chemistry system that
ChemLex Raises $45M to Expand AI Drug Discovery in Singapore. Key Takeaways ChemLex secures $45 million in new funding led by Granite Asia The company launches a self-driving AI chemistry lab as its global headquarters in Singapore The platform accelerates drug discovery by replacing manual workflows with robotics and autonomous systems
AI-for-Science Startup ChemLex Raises USD 45M, Launching Self . . . SINGAPORE, Dec 7, 2025 PRNewswire — ChemLex , a next-generation AI-for-science company, today announced the establishment of its global headquarters and self-driving laboratory in Singapore, alongside the close of a USD 45 million funding round led by Granite Asia Founded in 2022, ChemLex develops AI technologies that radically accelerate chemical discovery for the pharmaceutical
Chemlex raises USD45 million for AI drug discovery lab in . . . This press release was issued by ChemLex ChemLex, a next-generation AI-for-science company, today announced the establishment of its global headquarters and self-driving laboratory in Singapore, alongside the close of a USD 45 million funding round led by Granite Asia Founded in 2022, ChemLex develops AI technologies that radically accelerate chemical discovery for the pharmaceutical